Current Radiotherapy Considerations for Nasopharyngeal Carcinoma

被引:26
|
作者
Ng, Wai Tong [1 ,2 ,3 ]
Chow, James C. H. [4 ]
Beitler, Jonathan J. [5 ]
Corry, June [6 ]
Mendenhall, William [7 ]
Lee, Anne W. M. [1 ,2 ]
Robbins, K. Thomas [8 ]
Nuyts, Sandra [9 ]
Saba, Nabil F. [10 ]
Smee, Robert [11 ]
Stokes, William A. [12 ]
Strojan, Primoz [13 ]
Ferlito, Alfio
机构
[1] Univ Hong Kong, Shenzhen Hosp, Clin Oncol Ctr, Shenzhen 518009, Peoples R China
[2] Univ Hong Kong, Shenzhen Hosp, Shenzhen Key Lab Canc Metastasis & Personalized Th, Shenzhen 518009, Peoples R China
[3] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Peoples R China
[4] Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Peoples R China
[5] Knox Cty Hlth Clin, Rockland, ME 04841 USA
[6] St Vincents Hosp, Div Radiat Oncol, GenesisCare Radiat Oncol, Melbourne, Vic 3065, Australia
[7] Univ Florida, Dept Radiat Oncol, Coll Med, Gainesville, FL 32610 USA
[8] Southern Illinois Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Springfield, IL 62794 USA
[9] Univ Leuven, KU Leuven, Univ Hosp Leuven, Dept Radiat Oncol, B-3000 Leuven, Belgium
[10] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA 30322 USA
[11] Prince Wales Canc Ctr, Dept Radiat Oncol, Sydney, NSW 2031, Australia
[12] Emory Univ, Winship Canc Inst, Dept Radiat Oncol, Sch Med, Atlanta, GA 30322 USA
[13] Inst Oncol, Dept Radiat Oncol, Ljubljana 1000, Slovenia
关键词
nasopharyngeal cancer; radiotherapy; target delineation; adaptive planning; artificial intelligence; particle therapy; INTENSITY-MODULATED RADIOTHERAPY; CLINICAL TARGET VOLUME; LYMPH-NODE DISTRIBUTION; QUALITY-OF-LIFE; RADIATION-THERAPY; ARTIFICIAL-INTELLIGENCE; INDUCTION CHEMOTHERAPY; TREATMENT OUTCOMES; PROTON THERAPY; NCIC CTG;
D O I
10.3390/cancers14235773
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Nasopharyngeal carcinoma (NPC) is commonly treated using high-dose radiotherapy. Careful radiotherapy planning is crucial for the eradication of cancer cells while avoiding injuries to normal structures. This balance is often delicate given the complex anatomic location in which NPC is situated. This article highlights the considerations, practical pearls, and recent advances in the precise delivery of radiotherapy in NPC patients. Radiotherapy is the primary treatment modality for nasopharyngeal carcinoma (NPC). Successful curative treatment requires optimal radiotherapy planning and precise beam delivery that maximizes locoregional control while minimizing treatment-related side effects. In this article, we highlight considerations in target delineation, radiation dose, and the adoption of technological advances with the aim of optimizing the benefits of radiotherapy in NPC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Emerging radiotherapy technologies and trends in nasopharyngeal cancer
    Tseng, Michelle
    Ho, Francis
    Leong, Yiat Horng
    Wong, Lea Choung
    Tham, Ivan W. K.
    Cheo, Timothy
    Lee, Anne W. M.
    CANCER COMMUNICATIONS, 2020, 40 (09) : 395 - 405
  • [2] Precision radiotherapy for nasopharyngeal carcinoma
    Zhang, Zhenyu
    Chen, Xiangzhou
    Yuan, Taize
    PRECISION RADIATION ONCOLOGY, 2024, 8 (01): : 37 - 41
  • [3] Future of Radiotherapy in Nasopharyngeal Carcinoma
    Sun, Xue-Song
    Li, Xiao-Yun
    Chen, Qiu-Yan
    Tang, Lin-Quan
    Mai, Hai-Qiang
    BRITISH JOURNAL OF RADIOLOGY, 2019, 92 (1102)
  • [4] Current controversies in radiotherapy for nasopharyngeal carcinoma (NPC)
    Kam, Michael K. M.
    Wong, Frank C. S.
    Kwong, Dora L. W.
    Sze, Henry C. K.
    Lee, Anne W. M.
    ORAL ONCOLOGY, 2014, 50 (10) : 907 - 912
  • [5] Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders
    Yip, Pui Lam
    You, Rui
    Chen, Ming-Yuan
    Chua, Melvin L. K.
    CANCERS, 2024, 16 (02)
  • [6] Current state, challenges, and future perspective of adaptive radiotherapy: A narrative review of nasopharyngeal carcinoma
    Zhou, Xiate
    Shao, Tianchi
    Jia, Haijian
    Hou, Liqiao
    Tang, Xingni
    Yu, Changhui
    Zhou, Chao
    Zhou, Suna
    Yang, Haihua
    ORAL ONCOLOGY, 2024, 158
  • [7] Current understanding and management of nasopharyngeal carcinoma
    Yoshizaki, Tomokazu
    Ito, Makoto
    Murono, Shigekyuki
    Wakisaka, Naohiro
    Kondo, Satoru
    Endo, Kazuhira
    AURIS NASUS LARYNX, 2012, 39 (02) : 137 - 144
  • [8] Radiotherapy for nasopharyngeal cancer
    Blanchard, P.
    Biau, J.
    Huguet, F.
    Racadot, S.
    Berthold, C.
    Wong-Hee-Kam, S.
    Biston, M-C
    Maingon, P.
    CANCER RADIOTHERAPIE, 2022, 26 (1-2): : 168 - 173
  • [9] Current and emerging treatment options for nasopharyngeal carcinoma
    Spratt, Daniel E.
    Lee, Nancy
    ONCOTARGETS AND THERAPY, 2012, 5 : 297 - 308
  • [10] Current management of stage IV nasopharyngeal carcinoma without distant metastasis
    Ng, Wai Tong
    Corry, June
    Langendijk, Johannes A.
    Lee, Anne W. M.
    Makitie, Antti
    Mendenhall, William M.
    Rinaldo, Alessandra
    Rodrigo, Juan P.
    Saba, Nabil F.
    Smee, Robert
    Strojan, Primoz
    Suarez, Carlos
    Vermorken, Jan B.
    Ferlito, Alfio
    CANCER TREATMENT REVIEWS, 2020, 85